RHYTHM PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q3 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2016 to Q4 2024.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$41.3M, a 0.04% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$266M, a 44% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$266M, a 44% decline from 2023.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 2.9% decline from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 5.35% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$266M -$41.3M +$16K +0.04% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 -$266M -$43.9M +$68K +0.16% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$266M -$40.5M +$6.13M +13.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$272M -$140M -$87.4M -166% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$184M -$41.3M +$834K +1.98% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 -$185M -$44M -$4.69M -11.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$181M -$46.6M -$1.51M -3.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$179M -$52.5M +$160K +0.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$179M -$42.1M +$8.89M +17.4% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 -$188M -$39.3M +$4.97M +11.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$193M -$45.1M -$4.66M -11.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$188M -$52.7M -$18.3M -53.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$170M -$51M -$15.9M -45.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$154M -$44.2M -$9.96M -29% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$144M -$40.4M -$8.51M -26.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$136M -$34.4M +$902K +2.56% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$137M -$35.1M -$849K -2.48% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$136M -$34.3M +$2.82M +7.61% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$139M -$31.9M +$12.2M +27.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$151M -$35.3M -$4.78M -15.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 -$146M -$34.2M -$7.07M -26.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$139M -$37.1M -$17.9M -92.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$121M -$44.1M -$29.1M -194% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$91.9M -$30.5M -$13.5M -79.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$78.4M -$27.2M -$16.2M -147% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$62.2M -$19.2M -$11M -132% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$51.3M -$15M -$8.27M -122% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 -$43M -$17M -$10.6M -166% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 -$32.4M -$11M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$8.29M -$1.89M -29.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$6.75M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$6.39M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$6.4M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.